NMIBC risk factors in patients treated with BCG
- PMID: 35031786
- DOI: 10.1038/s41585-022-00565-6
NMIBC risk factors in patients treated with BCG
Comment on
-
Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin.Eur Urol Oncol. 2022 Feb;5(1):84-91. doi: 10.1016/j.euo.2021.11.006. Epub 2021 Dec 15. Eur Urol Oncol. 2022. PMID: 34920986 Free PMC article.
References
Original article
-
- Lobo, N. et al. Updated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non–muscle-invasive bladder cancer treated with bacillus Calmette-Guérin. Eur. Urol. Oncol. https://doi.org/10.1016/j.euo.2021.11.006 (2021) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
